Skip to content
Brand AI

NewAmsterdam Pharma

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    NewAmsterdam Pharma acquires obicetrapib rights from Amgen

    NewAmsterdam Pharma acquired the rights to obicetrapib (AMG 899) from Amgen. The financial terms were not disclosed.

    Source